id,source,text,arguments
0,EGRAM,A caspase-2 minigene construct could be made that is alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
1,EGRAM,A caspase-2 minigene construct could be made that is spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
2,EGRAM,A caspase-2 minigene construct could be made to be alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
3,EGRAM,A caspase-2 minigene construct could be made to be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
4,EGRAM,A caspase-2 minigene construct has been made that can be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
5,EGRAM,A caspase-2 minigene construct has been shown to be made that is alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
6,EGRAM,A caspase-2 minigene construct has been shown to be made that is spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
7,EGRAM,A caspase-2 minigene construct has the ability to be made to be alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
8,EGRAM,A caspase-2 minigene construct has the ability to be made to be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
9,EGRAM,A caspase-2 minigene construct is able to be made that is alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
10,EGRAM,A caspase-2 minigene construct is able to be made that is spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
11,EGRAM,A caspase-2 minigene construct is made that can be alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
12,EGRAM,A caspase-2 minigene construct is made that can be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
13,EGRAM,A caspase-2 minigene construct is observed to be made that is alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
14,EGRAM,A caspase-2 minigene construct is observed to be made that is spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
15,EGRAM,A caspase-2 minigene construct may be made that was alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
16,EGRAM,A caspase-2 minigene construct may be made that was spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
17,EGRAM,A caspase-2 minigene construct may have been made that can be alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
18,EGRAM,A caspase-2 minigene construct may have been made that can be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
19,EGRAM,A caspase-2 minigene construct was made that was alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
20,EGRAM,A caspase-2 minigene construct was made that was spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
21,EGRAM,A caspase-2 minigene construct will be made that is alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
22,EGRAM,A caspase-2 minigene construct will be made that is spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
23,EGRAM,A caspase-2 minigene construct would be made that could be alternatively spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
24,EGRAM,A caspase-2 minigene construct would be made that could be spliced in transfected cells and nuclear extracts.,"{'0': 'A caspase-2 minigene construct', '3': 'transfected cells and nuclear extracts'}"
25,EGRAM,"A pre-mRNA containing mutations in SE2, however, can be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
26,EGRAM,"A pre-mRNA containing mutations in SE2, however, has been alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
27,EGRAM,"A pre-mRNA containing mutations in SE2, however, has been shown to be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
28,EGRAM,"A pre-mRNA containing mutations in SE2, however, has the ability to be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
29,EGRAM,"A pre-mRNA containing mutations in SE2, however, is able to alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
30,EGRAM,"A pre-mRNA containing mutations in SE2, however, is alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
31,EGRAM,"A pre-mRNA containing mutations in SE2, however, is likely to be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
32,EGRAM,"A pre-mRNA containing mutations in SE2, however, is observed to be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
33,EGRAM,"A pre-mRNA containing mutations in SE2, however, may have been alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
34,EGRAM,"A pre-mRNA containing mutations in SE2, however, was alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
35,EGRAM,"A pre-mRNA containing mutations in SE2, however, will be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
36,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I alternatively splices only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
37,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I can alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
38,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I can splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
39,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has alternatively spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
40,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has been shown to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
41,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has been shown to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
42,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
43,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has the ability to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
44,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I has the ability to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
45,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is able to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
46,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is able to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
47,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is observed to alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
48,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I is observed to splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
49,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I may have alternatively spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
50,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I may have spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
51,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I splices only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
52,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I will alternatively splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
53,EGRAM,An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I will splice only 20% as efficiently as RNA 3F (Fig.1 C Left).,{'2': 'RNA 3I'}
54,EGRAM,"Consequently, exon 30 with the intron can be spliced.",{}
55,EGRAM,"Consequently, exon 30 with the intron has been shown to be spliced.",{}
56,EGRAM,"Consequently, exon 30 with the intron has been spliced.",{}
57,EGRAM,"Consequently, exon 30 with the intron has the ability to be spliced.",{}
58,EGRAM,"Consequently, exon 30 with the intron is able to be spliced.",{}
59,EGRAM,"Consequently, exon 30 with the intron is observed to be spliced.",{}
60,EGRAM,"Consequently, exon 30 with the intron may have been spliced.",{}
61,EGRAM,"Consequently, exon 30 with the intron was spliced.",{}
62,EGRAM,"Consequently, exon 30 with the intron will be spliced.",{}
63,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, can be spliced.",{}
64,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, has been shown to be spliced.",{}
65,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, has been spliced.",{}
66,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, has the ability to be spliced.",{}
67,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, is able to be spliced.",{}
68,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, is observed to be spliced.",{}
69,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, may have been spliced.",{}
70,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, was spliced.",{}
71,EGRAM,"Consequently, exon 30 with the intron, as our study suggested, will be spliced.",{}
72,EGRAM,Exons outside this size range are able to require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
73,EGRAM,Exons outside this size range are able to require additional exonic and/or intronic sequences to be spliced into the mature mRNA.,{'2': 'the mature mRNA'}
74,EGRAM,Exons outside this size range are effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
75,EGRAM,Exons outside this size range are observed to require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
76,EGRAM,Exons outside this size range are observed to require additional exonic and/or intronic sequences to be spliced into the mature mRNA.,{'2': 'the mature mRNA'}
77,EGRAM,Exons outside this size range are spliced into the mature mRNA.,{'2': 'the mature mRNA'}
78,EGRAM,Exons outside this size range have been effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
79,EGRAM,Exons outside this size range have been shown to require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
80,EGRAM,Exons outside this size range have been shown to require additional exonic and/or intronic sequences to be spliced into the mature mRNA.,{'2': 'the mature mRNA'}
81,EGRAM,Exons outside this size range have been spliced into the mature mRNA.,{'2': 'the mature mRNA'}
82,EGRAM,Exons outside this size range have required additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
83,EGRAM,Exons outside this size range have required additional exonic and/or intronic sequences to be spliced into the mature mRNA.,{'2': 'the mature mRNA'}
84,EGRAM,Exons outside this size range have the probability of requiring additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
85,EGRAM,Exons outside this size range have the probability of requiring additional exonic and/or intronic sequences to be spliced into the mature mRNA.,{'2': 'the mature mRNA'}
86,EGRAM,Exons outside this size range may have required additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
87,EGRAM,Exons outside this size range may have required additional exonic and/or intronic sequences to be spliced into the mature mRNA.,{'2': 'the mature mRNA'}
88,EGRAM,Exons outside this size range may require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
89,EGRAM,Exons outside this size range may require additional exonic and/or intronic sequences to be spliced into the mature mRNA.,{'2': 'the mature mRNA'}
90,EGRAM,Exons outside this size range require additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
91,EGRAM,Exons outside this size range require additional exonic and/or intronic sequences to be spliced into the mature mRNA.,{'2': 'the mature mRNA'}
92,EGRAM,Exons outside this size range required additional exonic and/or intronic sequences to be effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
93,EGRAM,Exons outside this size range required additional exonic and/or intronic sequences to be spliced into the mature mRNA.,{'2': 'the mature mRNA'}
94,EGRAM,Exons outside this size range were effectively spliced into the mature mRNA.,{'2': 'the mature mRNA'}
95,EGRAM,Exons outside this size range were spliced into the mature mRNA.,{'2': 'the mature mRNA'}
96,EGRAM,"However, a pre-mRNA containing mutations in SE2 can be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
97,EGRAM,"However, a pre-mRNA containing mutations in SE2 can be spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
98,EGRAM,"However, a pre-mRNA containing mutations in SE2 has been alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
99,EGRAM,"However, a pre-mRNA containing mutations in SE2 has been shown to be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
100,EGRAM,"However, a pre-mRNA containing mutations in SE2 has been shown to be spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
101,EGRAM,"However, a pre-mRNA containing mutations in SE2 has been spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
102,EGRAM,"However, a pre-mRNA containing mutations in SE2 has the ability to be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
103,EGRAM,"However, a pre-mRNA containing mutations in SE2 has the ability to be spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
104,EGRAM,"However, a pre-mRNA containing mutations in SE2 is able to alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
105,EGRAM,"However, a pre-mRNA containing mutations in SE2 is able to spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
106,EGRAM,"However, a pre-mRNA containing mutations in SE2 is alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
107,EGRAM,"However, a pre-mRNA containing mutations in SE2 is likely to be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
108,EGRAM,"However, a pre-mRNA containing mutations in SE2 is likely to be spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
109,EGRAM,"However, a pre-mRNA containing mutations in SE2 is observed to be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
110,EGRAM,"However, a pre-mRNA containing mutations in SE2 is observed to be spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
111,EGRAM,"However, a pre-mRNA containing mutations in SE2 may have been alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
112,EGRAM,"However, a pre-mRNA containing mutations in SE2 may have been spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
113,EGRAM,"However, a pre-mRNA containing mutations in SE2 was alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
114,EGRAM,"However, a pre-mRNA containing mutations in SE2 was spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
115,EGRAM,"However, a pre-mRNA containing mutations in SE2 will be alternatively spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
116,EGRAM,"However, a pre-mRNA containing mutations in SE2 will be spliced predominantly using the nt 3605 3 splice site.",{'0': 'a pre-mRNA containing mutations in SE2'}
117,EGRAM,The Supt4h gene can be normally spliced from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
118,EGRAM,The Supt4h gene can be spliced normally from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
119,EGRAM,The Supt4h gene has been normally spliced from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
120,EGRAM,The Supt4h gene has been shown to be normally spliced from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
121,EGRAM,The Supt4h gene has been shown to be spliced normally from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
122,EGRAM,The Supt4h gene has been spliced normally from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
123,EGRAM,The Supt4h gene has the ability to be normally spliced from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
124,EGRAM,The Supt4h gene has the ability to be spliced normally from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
125,EGRAM,The Supt4h gene is able to be normally spliced from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
126,EGRAM,The Supt4h gene is able to be spliced normally from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
127,EGRAM,The Supt4h gene is likely to be normally spliced from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
128,EGRAM,The Supt4h gene is likely to be spliced normally from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
129,EGRAM,The Supt4h gene is observed to be normally spliced from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
130,EGRAM,The Supt4h gene is observed to be spliced normally from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
131,EGRAM,The Supt4h gene may be normally spliced from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
132,EGRAM,The Supt4h gene may be spliced normally from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
133,EGRAM,The Supt4h gene may have been normally spliced from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
134,EGRAM,The Supt4h gene may have been spliced normally from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
135,EGRAM,The Supt4h gene was normally spliced from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
136,EGRAM,The Supt4h gene was spliced normally from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
137,EGRAM,The Supt4h gene will be normally spliced from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
138,EGRAM,The Supt4h gene will be spliced normally from five exons encoded by chromosome 11.,{'0': 'The Supt4h gene'}
139,EGRAM,"The casp-2 minigene (C2) can be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
140,EGRAM,"The casp-2 minigene (C2) can be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
141,EGRAM,"The casp-2 minigene (C2) has been efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
142,EGRAM,"The casp-2 minigene (C2) has been spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
143,EGRAM,"The casp-2 minigene (C2) has the ability to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
144,EGRAM,"The casp-2 minigene (C2) has the ability to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
145,EGRAM,"The casp-2 minigene (C2) is able to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
146,EGRAM,"The casp-2 minigene (C2) is able to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
147,EGRAM,"The casp-2 minigene (C2) is efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
148,EGRAM,"The casp-2 minigene (C2) is observed to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
149,EGRAM,"The casp-2 minigene (C2) is observed to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
150,EGRAM,"The casp-2 minigene (C2) is spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
151,EGRAM,"The casp-2 minigene (C2) may have been efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
152,EGRAM,"The casp-2 minigene (C2) may have been shown to be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
153,EGRAM,"The casp-2 minigene (C2) may have been shown to be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
154,EGRAM,"The casp-2 minigene (C2) may have been spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
155,EGRAM,"The casp-2 minigene (C2) will be efficiently spliced in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
156,EGRAM,"The casp-2 minigene (C2) will be spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).","{'0': 'The casp-2 minigene (C2)', '3': 'in vitro'}"
157,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being able to be efficiently spliced into the mRNA.,{'2': 'the mRNA'}
158,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being able to be spliced efficiently into the mRNA.,{'2': 'the mRNA'}
159,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being efficiently spliced into the mRNA.,{'2': 'the mRNA'}
160,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon being spliced efficiently into the mRNA.,{'2': 'the mRNA'}
161,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon efficiently spliced into the mRNA.,{'2': 'the mRNA'}
162,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having been efficiently spliced into the mRNA.,{'2': 'the mRNA'}
163,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having been spliced efficiently into the mRNA.,{'2': 'the mRNA'}
164,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having the ability to be efficiently spliced into the mRNA.,{'2': 'the mRNA'}
165,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon having the ability to be spliced efficiently into the mRNA.,{'2': 'the mRNA'}
166,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon observed to be efficiently spliced into the mRNA.,{'2': 'the mRNA'}
167,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon observed to be spliced efficiently into the mRNA.,{'2': 'the mRNA'}
168,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon shown to be efficiently spliced into the mRNA.,{'2': 'the mRNA'}
169,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon shown to be spliced efficiently into the mRNA.,{'2': 'the mRNA'}
170,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon spliced efficiently into the mRNA.,{'2': 'the mRNA'}
171,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that can be efficiently spliced into the mRNA.,{'2': 'the mRNA'}
172,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that can be spliced efficiently into the mRNA.,{'2': 'the mRNA'}
173,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been efficiently spliced into the mRNA.,{'2': 'the mRNA'}
174,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been shown to be efficiently spliced into the mRNA.,{'2': 'the mRNA'}
175,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been shown to be spliced efficiently into the mRNA.,{'2': 'the mRNA'}
176,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been spliced efficiently into the mRNA.,{'2': 'the mRNA'}
177,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has the ability to be efficiently spliced into the mRNA.,{'2': 'the mRNA'}
178,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has the ability to be spliced efficiently into the mRNA.,{'2': 'the mRNA'}
179,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is able to be efficiently spliced into the mRNA.,{'2': 'the mRNA'}
180,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is able to be spliced efficiently into the mRNA.,{'2': 'the mRNA'}
181,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is observed to be efficiently spliced into the mRNA.,{'2': 'the mRNA'}
182,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is observed to be spliced efficiently into the mRNA.,{'2': 'the mRNA'}
183,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that may have been efficiently spliced into the mRNA.,{'2': 'the mRNA'}
184,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that may have been spliced efficiently into the mRNA.,{'2': 'the mRNA'}
185,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that was efficiently spliced into the mRNA.,{'2': 'the mRNA'}
186,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that was spliced efficiently into the mRNA.,{'2': 'the mRNA'}
187,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that will be efficiently spliced into the mRNA.,{'2': 'the mRNA'}
188,EGRAM,The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that will be spliced efficiently into the mRNA.,{'2': 'the mRNA'}
189,EGRAM,"The pre-mRNAs from all of these genes are able to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.",{'0': 'The pre-mRNAs from all of these genes'}
190,EGRAM,"The pre-mRNAs from all of these genes are observed to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.",{'0': 'The pre-mRNAs from all of these genes'}
191,EGRAM,The pre-mRNAs from all of these genes being able to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
192,EGRAM,"The pre-mRNAs from all of these genes can be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.",{'0': 'The pre-mRNAs from all of these genes'}
193,EGRAM,"The pre-mRNAs from all of these genes have been shown to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.",{'0': 'The pre-mRNAs from all of these genes'}
194,EGRAM,"The pre-mRNAs from all of these genes have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.",{'0': 'The pre-mRNAs from all of these genes'}
195,EGRAM,"The pre-mRNAs from all of these genes have the ability to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.",{'0': 'The pre-mRNAs from all of these genes'}
196,EGRAM,The pre-mRNAs from all of these genes having been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
197,EGRAM,The pre-mRNAs from all of these genes having the ability to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
198,EGRAM,"The pre-mRNAs from all of these genes may have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.",{'0': 'The pre-mRNAs from all of these genes'}
199,EGRAM,The pre-mRNAs from all of these genes observed to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
200,EGRAM,The pre-mRNAs from all of these genes shown to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
201,EGRAM,The pre-mRNAs from all of these genes spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
202,EGRAM,The pre-mRNAs from all of these genes that are able to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
203,EGRAM,The pre-mRNAs from all of these genes that are observed to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
204,EGRAM,The pre-mRNAs from all of these genes that can be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
205,EGRAM,The pre-mRNAs from all of these genes that have been shown to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
206,EGRAM,The pre-mRNAs from all of these genes that have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
207,EGRAM,The pre-mRNAs from all of these genes that have the ability to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
208,EGRAM,The pre-mRNAs from all of these genes that may have been spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
209,EGRAM,The pre-mRNAs from all of these genes that were spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
210,EGRAM,The pre-mRNAs from all of these genes that will be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery.,{'0': 'The pre-mRNAs from all of these genes'}
211,EGRAM,"The pre-mRNAs from all of these genes were spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.",{'0': 'The pre-mRNAs from all of these genes'}
212,EGRAM,"The pre-mRNAs from all of these genes will be spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.",{'0': 'The pre-mRNAs from all of these genes'}
213,EGRAM,"The structure of different cDNA clones indicates that USF RNA can be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
214,EGRAM,"The structure of different cDNA clones indicates that USF RNA can be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
215,EGRAM,"The structure of different cDNA clones indicates that USF RNA has been differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
216,EGRAM,"The structure of different cDNA clones indicates that USF RNA has been shown to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
217,EGRAM,"The structure of different cDNA clones indicates that USF RNA has been shown to be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
218,EGRAM,"The structure of different cDNA clones indicates that USF RNA has been spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
219,EGRAM,"The structure of different cDNA clones indicates that USF RNA has the ability to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
220,EGRAM,"The structure of different cDNA clones indicates that USF RNA has the ability to be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
221,EGRAM,"The structure of different cDNA clones indicates that USF RNA is able to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
222,EGRAM,"The structure of different cDNA clones indicates that USF RNA is able to be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
223,EGRAM,"The structure of different cDNA clones indicates that USF RNA is observed to be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
224,EGRAM,"The structure of different cDNA clones indicates that USF RNA is observed to be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
225,EGRAM,"The structure of different cDNA clones indicates that USF RNA may have been differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
226,EGRAM,"The structure of different cDNA clones indicates that USF RNA may have been spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
227,EGRAM,"The structure of different cDNA clones indicates that USF RNA was differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
228,EGRAM,"The structure of different cDNA clones indicates that USF RNA was spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
229,EGRAM,"The structure of different cDNA clones indicates that USF RNA will be differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
230,EGRAM,"The structure of different cDNA clones indicates that USF RNA will be spliced, and alternative exon usage may regulate the levels of functional USF protein.",{'0': 'USF RNA'}
231,EGRAM,We also identified four transcriptional units being able to be differentially spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
232,EGRAM,We also identified four transcriptional units being able to be spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
233,EGRAM,We also identified four transcriptional units differentially spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
234,EGRAM,We also identified four transcriptional units having been shown to be differentially spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
235,EGRAM,We also identified four transcriptional units having been shown to be spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
236,EGRAM,We also identified four transcriptional units observed to be differentially spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
237,EGRAM,We also identified four transcriptional units observed to be spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
238,EGRAM,We also identified four transcriptional units spliced but containing no obvious open reading frame.,{'0': 'four transcriptional units'}
239,EGRAM,We also identified four transcriptional units that are able to be differentially spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
240,EGRAM,We also identified four transcriptional units that are able to be spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
241,EGRAM,We also identified four transcriptional units that are observed to be differentially spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
242,EGRAM,We also identified four transcriptional units that are observed to be spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
243,EGRAM,We also identified four transcriptional units that can be differentially spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
244,EGRAM,We also identified four transcriptional units that can be spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
245,EGRAM,We also identified four transcriptional units that could have been differentially spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
246,EGRAM,We also identified four transcriptional units that could have been spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
247,EGRAM,We also identified four transcriptional units that have been differentially spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
248,EGRAM,We also identified four transcriptional units that have been shown to be differentially spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
249,EGRAM,We also identified four transcriptional units that have been shown to be spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
250,EGRAM,We also identified four transcriptional units that have been spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
251,EGRAM,We also identified four transcriptional units that may be differentially spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
252,EGRAM,We also identified four transcriptional units that may be spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
253,EGRAM,We also identified four transcriptional units that may have been differentially spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
254,EGRAM,We also identified four transcriptional units that may have been spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
255,EGRAM,We also identified four transcriptional units that were differentially spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
256,EGRAM,We also identified four transcriptional units that were spliced but contained no obvious open reading frame.,{'0': 'four transcriptional units'}
257,EGRAM,We also identified four transcriptional units that will be differentially spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
258,EGRAM,We also identified four transcriptional units that will be spliced but contain no obvious open reading frame.,{'0': 'four transcriptional units'}
259,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate can be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
260,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate can be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
261,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been shown to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
262,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been shown to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
263,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
264,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has been spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
265,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has the ablity to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
266,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate has the ablity to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
267,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is able to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
268,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is able to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
269,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is observed to be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
270,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is observed to be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
271,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
272,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate is spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
273,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
274,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
275,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may have been spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
276,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate may have been spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
277,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate will be spliced following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
278,EGRAM,"When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate will be spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).",{'0': 'the C2Gloi2 substrate'}
